USPTO serial 97175653
NOCTURNAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 22, 2023
- Examiner
- SIRIGNANO, EMMA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NOCTURNAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nocturnal Product Development, LLC
Durham, NC
Other trademarks owned by Nocturnal Product Development, LLC
Nocturnal Product Development, LLC
Durham, NC
Other trademarks owned by Nocturnal Product Development, LLC
Nocturnal Product Development, LLC
Durham, NC
Other trademarks owned by Nocturnal Product Development, LLC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | business consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approval, and assisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting services, namely, assisting with clinical trial submissions, namely, regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting services, namely, assisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting services, namely, project management services to identify and mitigate potential risks in complex projects; business consulting services, namely, consultation in the fields of medical products and medical devices | ACTIVE | — |
| 036 | business financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials | ACTIVE | — |
| 042 | product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software for use with medical products and medical devices including topical electronic medical devices, active electronic implants, implantable pacemakers, defibrillators, diagnostic catheters, ablation catheters, and neurostimulators; business product development consulting services, namely, providing assistance in the development of leading-edge technologies for medical, biopharmaceutical, and biotechnology companies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nocturnal Product Development, LLC
- Other trademarks owned by Nocturnal Product Development, LLC
- Other trademarks owned by Nocturnal Product Development, LLC
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named NOCTURNAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 22, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 6, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 6, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 20, 2021 | NWAP | NEW APPLICATION ENTERED | — |